530697 Stock Overview
Zenlabs Ethica Limited markets and distributes pharmaceutical products in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
Zenlabs Ethica Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹40.98 |
| 52 Week High | ₹70.00 |
| 52 Week Low | ₹31.30 |
| Beta | -0.41 |
| 1 Month Change | -10.52% |
| 3 Month Change | -10.91% |
| 1 Year Change | -15.05% |
| 3 Year Change | 31.77% |
| 5 Year Change | -9.84% |
| Change since IPO | 2,768.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| 530697 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -8.8% | -1.4% | -1.9% |
| 1Y | -15.0% | 39.8% | 41.0% |
Return vs Industry: 530697 underperformed the Indian Healthcare industry which returned 39.8% over the past year.
Return vs Market: 530697 underperformed the Indian Market which returned 41% over the past year.
Price Volatility
| 530697 volatility | |
|---|---|
| 530697 Average Weekly Movement | 5.7% |
| Healthcare Industry Average Movement | 5.9% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in IN Market | 9.4% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 530697 has not had significant price volatility in the past 3 months.
Volatility Over Time: 530697's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 69 | Sanjeev Singal | www.zenlabsethica.com |
Zenlabs Ethica Limited markets and distributes pharmaceutical products in India. It markets analgesics and anti-inflammatory drugs; skin preparations; drugs for neurological and GIT disorders; ear, eye, and nasal drops; anti-diabetic, anti-depressant, anti-infective, anti-emetic, anti-hypertensive, anti-allergic, and anti-cold and cough syrups; steroids and anabolic steroids; nutraceuticals; antacids, enzymes, and appetite stimulants; ayurvedic preparations; soaps; dusting powders; soaps; and other pharmaceutical drugs. The company is also involved in the private label manufacturing of various pharmaceutical products, such as tablets, capsules, injections, syrups, and ointments; and therapeutics, such as anti-infective, anti-obesity, anti-bacterial, anti-hypertensives, anti-fungal, pain killers, and nutritional supplements.
Zenlabs Ethica Limited Fundamentals Summary
| 530697 fundamental statistics | |
|---|---|
| Market cap | ₹266.78m |
| Earnings (TTM) | ₹4.21m |
| Revenue (TTM) | ₹588.62m |
63.3x
P/E Ratio0.5x
P/S RatioIs 530697 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 530697 income statement (TTM) | |
|---|---|
| Revenue | ₹588.62m |
| Cost of Revenue | ₹437.88m |
| Gross Profit | ₹150.75m |
| Other Expenses | ₹146.53m |
| Earnings | ₹4.21m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.65 |
| Gross Margin | 25.61% |
| Net Profit Margin | 0.72% |
| Debt/Equity Ratio | 128.3% |
How did 530697 perform over the long term?
See historical performance and comparison